Syndax Pharmaceuticals Inc (SNDX)
R&D Expense Growth
15.62%
Quarterly · Period ending:
SNDX R&D Expense Growth
Latest reported15.62%period ending
Latest reported15.62%period ending
SNDX Quarterly R&D Growth (QoQ) (0.00% → 15.62%)
Latest values, visible window
High-resolution chart · PNG
SNDX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 15.619% | |
| -25.1726% | |
| 39.7317% | |
| -9.5569% | |
| 0.9589% | |
| -5.9409% | |
| -7.6679% | |
| 45.8658% | |
| -13.8728% | |
| 2.478% | |
| 41.0341% | |
| 12.4353% | |
| 2.0849% | |
| 6.9502% | |
| 18.3636% | |
| -9.5278% | |
| -0.9593% | |
| 25.6151% | |
| -6.6625% | |
| 51.7752% | |
| -22.8578% | |
| 40.8968% | |
| 7.7318% | |
| 31.6641% | |
| 14.4426% | |
| 0.6314% | |
| -4.2427% | |
| -19.2596% | |
| 8.9636% | |
| -28.7087% | |
| 12.2455% | |
| -5.0906% | |
| -3.1814% | |
| -7.5908% | |
| 36.1913% | |
| 23.5855% | |
| 3.2454% | |
| 12.7213% | |
| -30.9598% | |
| 100.1957% | |
| 28.1028% | |
| 85.0019% | |
| -12.8369% | |
| 30.6913% | |
| 31.805% | |
| 18.4192% | |
| -14.8625% | |
| -64.9364% | |
| 128.0767% | |
| 101.7941% | |
| 25.3254% | |
| 15.5951% | |
| 27.5742% | |
| 105,230.8824% | |
| 0% |